Tempus AI, Inc.
USUSDTempus AI, Inc. (US:TEM) — Computer Software: Programming Data Processing. Nombre de places boursières sur lesquelles les actions de la société sont cotées : 3. Sur cette page : cours et graphique, dividendes, principaux actionnaires et historique du nombre d'actions.
À propos de l'entreprise
- Site web
- tempus.com
- Secteur
- Technology · Computer Software: Programming Data Processing
- Siège social
- CHICAGO, United States
- PDG
- Mr. Eric P. Lefkofsky J.D.
- Employés
- 3 800
- Actions en circulation
- 175.39 M
- Flottant
- 116.3 M
- Capitalisation boursière
- 15.35 Md USD
- Initiés
- 36.77%
- Investisseurs institutionnels
- 59.28%
- Secteur d'activité (SIC)
- Services-Computer Programming, Data Processing, Etc.
- ISIN
- US88023B1035
Description
Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also provides Lens, a software application for life sciences and advanced precision research; diagnostics services, such as NGS diagnostics, PCR profiling, and other anatomic and molecular pathology tests; and large-panel solid tumor and hematologic testing through multiple assays, with its core clinical assay (xT and xR) offering large panel DNA, RNA full transcriptome, and incidental germline findings through normal blood or saliva analyses. In addition, it provides genetic tests focused on inherited conditions; an nP assay for pharmacogenomic testing for patients with psychiatric conditions, including depression, general anxiety disorder, bipolar disorder, and other relevant diagnoses; Insights, which licenses libraries of linked, de-identified clinical, molecular, and imaging data; Organoids, a tumor derived biological modeling. Further, the company offers Trials for clinical trial matching services; Next, an AI platform; Algos, an algorithm-based diagnostics application. It has Strategic Collaborations with AstraZeneca AB, Pathos AI, Inc., GlaxoSmithKline, Merck, and Recursion Pharmaceuticals, Inc. Additionally, it also has a strategic collaboration with Blood Cancer United to develop registry for pediatric acute myeloid leukemia. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc. in January 2023. Tempus AI, Inc. was incorporated in 2015 and is headquartered in Chicago, Illinois.
Dividendes
Aucun versement de dividendes n'a été trouvé (vérifié le 09.10.2026). L'entreprise ne verse probablement pas de dividendes.
Actualités de cette semaine
Pas encore d'actualités du site de l'entreprise.
Principaux actionnaires
| Détenteur | Participation | Actions | Date du rapport |
|---|---|---|---|
| ARK Investment Managemen… | 5.71% | 10.02 M | 2026-06-30 |
| Blackrock Inc. | 4.73% | 8.29 M | 2026-06-30 |
| BAILLIE GIFFORD & CO | 4.67% | 8.19 M | 2026-06-30 |
| ARK ETF Trust-ARK Innova… | 3.11% | 5.46 M | 2026-08-31 |
| Softbank Group Corporati… | 3.08% | 5.41 M | 2026-06-30 |
| JPMORGAN CHASE & CO | 2.84% | 4.99 M | 2026-06-30 |
| Vanguard Capital Managem… | 2.84% | 4.99 M | 2026-06-30 |
| Vanguard Portfolio Manag… | 2.8% | 4.91 M | 2026-06-30 |
| Sumitomo Mitsui Trust Gr… | 2.33% | 4.09 M | 2026-06-30 |
| Amova Asset Management A… | 2.33% | 4.09 M | 2026-06-30 |
| Goldman Sachs Group Inc | 2.14% | 3.76 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.05% | 3.6 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 1.48% | 2.6 M | 2026-06-30 |
| ARK ETF Trust-ARK Genomi… | 1.44% | 2.52 M | 2026-08-31 |
| VANGUARD WORLD FUND-Vang… | 1.26% | 2.2 M | 2026-05-31 |
| VANGUARD INDEX FUNDS-Van… | 0.86% | 1.5 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 0.67% | 1.18 M | 2026-06-30 |
| EntrepreneurShares Serie… | 0.44% | 775 100 | 2026-06-30 |
| iShares Trust-iShares Bi… | 0.44% | 774 489 | 2026-07-31 |
| Franklin Custodian Funds… | 0.43% | 750 000 | 2026-06-30 |
| POLOVIN ANDREW (Officer) | ≈0.08% | 138 140 | 2026-08-19 |
| ROGERS JAMES WILLIAM (Ch… | ≈0.06% | 106 024 | 2026-08-19 |
| LEONSIS THEODORE J (Dire… | ≈0.05% | 88 180 | 2026-05-21 |
| SCHOENHERR THOMAS EDWARD… | ≈0.05% | 87 021 | 2026-08-21 |
| PHELPS ERIK J. (Officer) | ≈0.05% | 79 816 | 2026-02-19 |
| BARTOLUCCI RYAN M (Offic… | ≈0.04% | 67 866 | 2026-08-18 |
| FUKUSHIMA RYAN (Officer) | — | — | 2026-09-01 |
| KEYWELL BRADLEY A (Forme… | — | — | 2025-01-17 |
| LEFKOFSKY ERIC PAUL (Chi… | — | — | 2026-09-22 |
| RED SKY VENTURES L L C (… | — | — | 2024-12-11 |
